Meltz Mark A

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Meltz Mark A
CIK #0001771329
EDGAR Form CIK 2011 - 2026
3 [0001771329]
4 [0001771329]
Form 3/4/5 Subject 2011 - 2026
Lyell Immunopharma Inc
Meltz Mark A
Kinnate Biopharma Inc
Audentes Therapeutics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Lyell Immunopharma Inc LYEL
Option (right to buy) · derivative
2026-02-10 Grant 50,000 $0.00
Lyell Immunopharma Inc LYEL
Option (right to buy) · derivative
2025-06-09 Grant 100,000 $0.00
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
2024-04-03 Disposed to issuer 215,000
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
2024-04-03 Disposed to issuer 135,000
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
2024-04-03 Disposed to issuer 384,508
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
2024-04-03 Disposed to issuer 100,000
Kinnate Biopharma Inc KNTE
Common Stock
2024-04-03 Disposed to issuer 27,578
Kinnate Biopharma Inc KNTE
Stock Option (right to buy) · derivative
2024-04-03 Disposed to issuer 121,503
Kinnate Biopharma Inc KNTE
Common Stock
2024-03-01 Tax withheld 558 $2.59 1,445
Kinnate Biopharma Inc KNTE
Common Stock
2023-12-01 Tax withheld 541 $2.25 1,217
Kinnate Biopharma Inc KNTE
Common Stock
2023-09-01 Tax withheld 541 $2.35 1,271
Kinnate Biopharma Inc KNTE
Common Stock
2023-06-01 Tax withheld 541 $4.30 2,326
Kinnate Biopharma Inc KNTE
Common Stock
2023-03-01 Tax withheld 638 $5.21 3,324
Kinnate Biopharma Inc KNTE
Employee Stock Option (right to buy) · derivative
2023-02-10 Grant 215,000 $0.00
Kinnate Biopharma Inc KNTE
Common Stock
2022-12-01 Tax withheld 541 $7.75 4,193
Kinnate Biopharma Inc KNTE
Common Stock
2022-09-01 Grant 25,000 $0.00
Kinnate Biopharma Inc KNTE
Employee Stock Option (right to buy) · derivative
2022-02-11 Grant 135,000 $0.00
Kinnate Biopharma Inc KNTE
Employee Stock Option (right to buy) · derivative
2021-02-12 Grant 100,000 $0.00
Audentes Therapeutics Inc BOLD
Common Stock
2020-01-15 Tender 32,705 $60.00 1,962,300
Audentes Therapeutics Inc BOLD
Stock Option (Right to Buy) · derivative
2020-01-15 Disposed to issuer 104,000
showing 20 of 23 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com